» Long Acting Neuraminidase Inhibitor (LANI) Phase II Completed - Phase III Scheduled -Naturally Acquired Influenza A Or B
Biota Holdings Limited (ASX:BTA)(PINK:BTAHY) announced that its second generation, influenza treatment, CS-8958, has successfully completed its initial Phase II clinical evaluation, showing…